Surgisphere scandal: what happened?
A questionable data set from a mysterious company forced high-profile retractions, cast doubt on drug trials and tarnished public trust amid a deadly pandemic. But the warning signs had been there all along, reports The Scientist. Its investigation describes a series of missed opportunities, wishful thinking and signs that a similar snafu could happen again.
The Scientist | 16 min read
No hay comentarios:
Publicar un comentario